Literature DB >> 2303829

Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease.

D Montaldi1, D N Brooks, J H McColl, D Wyper, J Patterson, E Barron, J McCulloch.   

Abstract

Single photon emission computed tomography (SPECT) with 99mTc-HMPAO was used to image 26 patients with dementia of the Alzheimer type (DAT) and 10 healthy controls. Regional cerebral blood flow (rCBF) data indicated a relative sparing of the occipital regions in DAT. Normalisation to occipital flow illustrated highly significant CBF deficits in a number of cortical regions, particularly in the left and right posterior--temporal cortex in DAT compared to controls. The cognitive performance of DAT patients was measured using a clinical cognitive assessment procedure (CAMCOG) and numerous correlations between these scores and rCBF were obtained. The implications and value of this investigative technique are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303829      PMCID: PMC1014094          DOI: 10.1136/jnnp.53.1.33

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  A SIMPLIFIED PAIRED-ASSOCIATE TEST FOR ELDERLY HOSPITAL PATIENTS.

Authors:  B ISAACS; F A WALKEY
Journal:  Br J Psychiatry       Date:  1964-01       Impact factor: 9.319

Review 3.  Clinical and neuropsychological assessment of dementia.

Authors:  F A Huppert; E Tym
Journal:  Br Med Bull       Date:  1986-01       Impact factor: 4.291

Review 4.  Perfusion and receptor SPECT in the dementias--George Taplin memorial lecture.

Authors:  B L Holman
Journal:  J Nucl Med       Date:  1986-06       Impact factor: 10.057

5.  Cerebral blood flow in dementias.

Authors:  J Risberg
Journal:  Dan Med Bull       Date:  1985-02

6.  L-dopa-induced respiratory disturbance in Parkinson's disease suppressed by tiapride.

Authors:  J De Keyser; W Vincken
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

7.  Senile dementia of the Alzheimer type.

Authors:  R D Terry; R Katzman
Journal:  Ann Neurol       Date:  1983-11       Impact factor: 10.422

8.  Positron emission tomography in Alzheimer's disease.

Authors:  R Duara; C Grady; J Haxby; M Sundaram; N R Cutler; L Heston; A Moore; N Schlageter; S Larson; S I Rapoport
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

9.  Cortical abnormalities in Alzheimer's disease.

Authors:  N L Foster; T N Chase; L Mansi; R Brooks; P Fedio; N J Patronas; G Di Chiro
Journal:  Ann Neurol       Date:  1984-12       Impact factor: 10.422

10.  Alcohol availability, alcohol consumption and alcohol-related damage. II. The role of sociodemographic factors.

Authors:  L Gliksman; B R Rush
Journal:  J Stud Alcohol       Date:  1986-01
View more
  27 in total

1.  Cortical region of interest definition on SPECT brain images using X-ray CT registration.

Authors:  N Tzourio; M Joliot; B M Mazoyer; V Charlot; D Sutton; G Salamon
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

2.  A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.

Authors:  M O Habert; U Spampinato; J L Mas; M L Piketty; M C Bourdel; J de Recondo; P Rondot; S Askienazy
Journal:  Eur J Nucl Med       Date:  1991

3.  Association between medial temporal lobe atrophy on CT and parietotemporal uptake decrease on SPECT in Alzheimer's disease.

Authors:  I Lavenu; F Pasquier; F Lebert; B Jacob; H Petit
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

4.  Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease.

Authors:  G Rodriguez; S Morbelli; A Brugnolo; P Calvini; N Girtler; A Piccardo; N J Dougall; K P Ebmeier; J C Baron; F Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06-02       Impact factor: 9.236

5.  A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease.

Authors:  T J Müller; J Thome; R Chiaramonti; T Dierks; K Maurer; A J Fallgatter; L Frölich; M Scheubeck; W K Strik
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

6.  Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.

Authors:  Michio Takahashi; Yasunori Oda; Toshiyuki Okubo; Yukihiko Shirayama
Journal:  J Neural Transm (Vienna)       Date:  2017-05-16       Impact factor: 3.575

Review 7.  Pain in people with Alzheimer disease: potential applications for psychophysical and neurophysiological research.

Authors:  Todd B Monroe; John C Gore; Li Min Chen; Lorraine C Mion; Ronald L Cowan
Journal:  J Geriatr Psychiatry Neurol       Date:  2012-12-31       Impact factor: 2.680

8.  Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease.

Authors:  Min Sheng; Hanzhang Lu; Peiying Liu; Yang Li; Harshan Ravi; Shin-Lei Peng; Ramon Diaz-Arrastia; Michael D Devous; Kyle B Womack
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT.

Authors:  H Karbe; A Kertesz; J Davis; B J Kemp; F S Prato; R L Nicholson
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

10.  Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia.

Authors:  P R Talbot; J J Lloyd; J S Snowden; D Neary; H J Testa
Journal:  Eur J Nucl Med       Date:  1994-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.